e.g. mhealth
Search Results (1 to 3 of 3 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 1 JMIR Biomedical Engineering
- 1 JMIR Formative Research
- 1 JMIR mHealth and uHealth
- 0 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Research Protocols
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
The primary outcome measure was pain intensity. An 11-point numeric rating scale (NRS) assessed participants’ pain intensity. A change of 1‐2 points was considered clinically relevant [29]. The secondary outcome was well-being, measured using an 11-point Likert scale. A score of zero indicates poor well-being, while a score of 10 indicates perfect well-being. Data were collected at baseline (t0), 4 weeks (t1), and 8 weeks (t2).
JMIR Form Res 2025;9:e57826
Download Citation: END BibTex RIS
The extent of benefits observed differs depending on the exercise type, intensity, and duration. Various recent clinical trials have concluded that moderate- to high-intensity exercise several times per week, when maintained over extended periods, is associated with slower deterioration of motor symptoms in PD [4,5].
JMIR Biomed Eng 2023;8:e51515
Download Citation: END BibTex RIS
We tested whether headache and migraine frequency, headache and migraine intensity, and days with intake of acute medication differed between baseline and after 6 months. In extension analyses, we compared outcomes at baseline to those at 12 months.
M-sense is a certified German headache app developed by Newsenselab. In Germany, Austria, and Switzerland, it has been available for Android since 2016 and for i OS since 2017 [12].
JMIR Mhealth Uhealth 2021;9(7):e26401
Download Citation: END BibTex RIS